Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
Pharmavite annexes FoodState; CSPI urges ban on caffeine powder; NCCIH debuts at NIH; Gravity in Hantain’s orbit; SDC Nutrition in Costa Rica, Cayman Islands; Mannatech in Spain; and Food Advisory Committee nominations.
You may also be interested in...
Supplement Industry Critics On Agenda For FDA's Ingredient List Meeting
FDAs Oct. 3 meeting agenda includes Pieter Cohen, Harvard Medical School professor; Consumers Union Programs Director Chuck Bell; Laura MacCleery, Center for Science in the Public Interest regulatory affairs director; and Stephanie Scarmo, Pew Charitable Trusts Health Care Products Project officer.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.